Skip to content
10-Q

Quarterly Report

IMMAGE BIOTHERAPEUTICS CORP.

0001640334-16-001407

← back to feed
Filed
Jul 15, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Jul 10, 2016 146.74M sh
Cash And Equivalents Q3 2016 · May 31, 2016 $265.49K
Cash And Equivalents Q3 2016 · Aug 31, 2015 $32.68K
Cash And Equivalents Q3 2016 · May 31, 2015 −$10.71K
Cash And Equivalents Q3 2016 · Aug 31, 2014 $2.34K
Stockholders Equity Q3 2016 · May 31, 2016 $249.28K
Stockholders Equity Q3 2016 · Aug 31, 2015 $28.76K
Current Liabilities Q3 2016 · May 31, 2016 $55.85K
Current Liabilities Q3 2016 · Aug 31, 2015 $51.4K
Total Liabilities Q3 2016 · May 31, 2016 $55.85K
Total Liabilities Q3 2016 · Aug 31, 2015 $51.4K
Current Assets Q3 2016 · May 31, 2016 $265.49K
Current Assets Q3 2016 · Aug 31, 2015 $33.58K
Total Assets Q3 2016 · May 31, 2016 $305.13K
Total Assets Q3 2016 · Aug 31, 2015 $80.17K
Sga Expense Q3 2016 · May 31, 2016 $25.97K
Sga Expense Q3 2016 · May 31, 2016 $73.86K
Sga Expense Q3 2016 · May 31, 2015 $2.15K
Sga Expense Q3 2016 · May 31, 2015 $4.27K
Rd Expense Q3 2016 · May 31, 2016 $9.71K
Rd Expense Q3 2016 · May 31, 2016 $44.39K
Net Income Q3 2016 · May 31, 2016 −$50.86K
Net Income Q3 2016 · May 31, 2016 −$154.48K
Net Income Q3 2016 · May 31, 2015 −$14.74K
Net Income Q3 2016 · May 31, 2015 −$24.75K